Aurobindo Pharma Ltd (AUROPHARMA) — Announcement | 30 September 2026

30 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Acrotech Biopharma launches ADQUEY™ in U.S. dermatology market

💡 Investor Takeaway

Routine procedural filing with no direct impact on shareholders.

Aurobindo Pharma's subsidiary Acrotech Biopharma launched ADQUEY™ (difamilast 1% ointment), a non-steroidal topical PDE4 inhibitor for atopic dermatitis, in the U.S. market and established a dedicated dermatology business unit to support commercialization and future growth in specialty dermatology, targeting a $1.3 billion market opportunity.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AUROPHARMA ✨ Ask AI About This

About Aurobindo Pharma Ltd (AUROPHARMA)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹97,986.86 CrP/E: 26.6ROE: 9.8%ROCE: 12.8%Div Yield: 0.23%

View full AUROPHARMA stock details →

📡 Get AI alerts when AUROPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AUROPHARMA — Free

💡 Ask AI about this filing

"How will ADQUEY impact Aurobindo's revenue diversification?""What is the projected market share for ADQUEY in the U.S. dermatology segment?""When will Acrotech's dermatology unit achieve profitability?"

Ask AI Free →

📊 More AUROPHARMA filings

🔴 Announcement — 29 September 2026Aurobindo Pharma disclosed a GST appellate order confirming reversal of Rs. 2.56 crore excess input ...
Announcement — 24 September 2026Aurobindo Pharma announced that its trading window will close on October 1, 2026, for all designated...
🔴 Announcement — 21 September 2026Aurobindo Pharma announced its participation in a JP Morgan Healthcare Trip investor meeting in Hyde...
🔴 Announcement — 15 September 2026Aurobindo Pharma announced USFDA final approval for its first metered-dose inhaler, Beclomethasone D...
🔴 Announcement — 15 September 2026Aurobindo Pharma announced the completion of a US FDA inspection at its Apitoria Pharma subsidiary's...

See all AUROPHARMA filings →

🔥 Also filed on 30 September 2026

544150KP Green Engineering LtdAnnouncement NINSYSNINtec Systems LtdAnnouncement ELANDE-Land Apparel LtdAnnouncement MOTILALOFSMotilal Oswal Financial Services LtdCorporate Action BANKINDIABank of IndiaAnnouncement SUNFLAGSunflag Iron & Steel Company LtdAnnouncement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AUROPHARMA files new disclosures

Track AUROPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.